Scharrenburg; Gustaaf J.M. Van
Patent Applications and Registrations
Patent applications and USPTO patent grants for Scharrenburg; Gustaaf J.M. Van.The latest application filed is for "aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition".
- Scharrenburg; Gustaaf J.M. Van - Weesp NL
| Patent | Date |
|---|---|
| Aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition App 20060122247 - Feenstra; Roelof W. ; et al. | 2006-06-08 |
| Diazabicyclo alkane derivatives with nk1 antagonistic activity App 20050119267 - Boer, Dirk de ; et al. | 2005-06-02 |
| Partial dopamine-D 2 receptor agonist plus serotonin and/oder noradrenaline inhibitor activity App 20050038015 - Bronzova, Juliana B ; et al. | 2005-02-17 |
| Phenylpiperazines App 20030162791 - Feenstra, Roelof W ; et al. | 2003-08-28 |
| Piperazine and piperidine compounds App 20030119849 - Feenstra, Roelof W. ; et al. | 2003-06-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 